Egland scores Teddy Bear Toss goal but Pats lose in OT
1h ago
Jace Egland's second career WHL goal will be as memorable as his first. The 17-year-old scored the 2024 Regina Pats Tedd...
8:30 – The crash of Ethiopian Airlines Flight 302 on Sunday left 157 people dead, including 18 Canadians, and has created significant concerns about the Boeing 737 Max 8 plane. Many countries, including the entire EU, have grounded the planes for safety reasons. Despite the concerns, Canada and the USA both continue to operate them (Canadian airline Sunwing has grounded their Max 8s, but Air Canada and Westjet continue to fly them). To help explain where these concerns come from and what can be done about it, John is joined by Karl Moore, a professor at McGill and aviation expert who has served as consultant to Air Canada, Lufthansa, and British Airways.
LIVE: Karl Moore, aviation expert and associate professor of business at McGill.
9:00 – The Hour of the Big Stories… Open Session
10:00 – Irshad Manji, the author and advocate who was was once called “Osama bin Laden’s worst nightmare” by the New York Times, has recently released a new book. In “Don’t Label Me: An Incredible Conversation for Divided Times,” she explores the best ways of celebrating diversity in today’s politically polarized climate. Manji argues that by using labels such as “bigot,” we might actually be increasing division rather than reducing it. According to Manji, labels do more harm than good. She joins John now to discuss the book and why labelling people is so common today.
LIVE: Irshad Manji, best-selling author of “Don’t Label Me.”
11:00 – It’s time for Saskatchewan’s Smartest Radio Listener! Powered by Bathfitter. Your chance for fame, acclaim and to prove just how smart you are. Not only do you get bragging rights, you’ll win a $50 gift card for Mr. Mikes.
12:00 – Dr. Humphrey Fonge, a U of S medical researcher, is developing a radioactive antibody that kills colorectal cancer cells without harming healthy cells. Described as “assassin” antibodies, the treatment could lead to significant progress for late-stage patients, who generally have a low life expectancy. The treatment is already proving highly effective in mice, and Fonge recently received a major grant from the Canadian Institutes of Health Research to begin human trials. Fonge joins John now to discuss the new treatment.
LIVE: Dr. Humphrey Fonge, Radiopharmacist at the Saskatoon Health Region and Assistant Professor of Medical Imaging at the U of S College of Medicine.